Jason Napodano has been with Zacks Investment Research since 2003 working as the Senior

Pharmaceutical & Biotechnology analyst and team leader for the Healthcare group.

Before joining Zacks, Jason served as Vice President and Senior Equity Analyst covering pharmaceuticals and biotechnology for Eastover Capital Management from 1999 to 2002. Prior to Eastover, Jason worked as a laboratory research scientist for TechLab, Inc., a

biotechnology company focused on the development of diagnostic kits and vaccines for infectious disease, from 1995 to 1998.

Jason holds a BS from Virginia Tech in Biochemistry and a MBA from Wake Forest University.

Jason is also a Chartered Financial Analyst.